Evidence map›Paper›PMID 40322605›Full record

ReviewCureus2025

Breast Cancer Detection Using Convolutional Neural Networks: A Deep Learning-Based Approach.

Faizan Nasir, Shanur Rahman, Nazim Nasir

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Faizan NasirComputer Science, Aligarh Muslim University, Aligarh, IND.
Shanur RahmanComputer Engineering, Aligarh Muslim University, Aligarh, IND.
Nazim NasirAnatomical Sciences, King Khalid University, Abha, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains one of the leading causes of mortality among women, particularly in low- and middle-income countries, where limited healthcare access and delayed diagnosis contribute to poor outcomes. Deep learning, especially convolutional neural networks (CNNs), has shown remarkable efficacy in breast cancer detection through automated image analysis, reducing reliance on manual interpretation. This study provides a comprehensive review of recent advancements in CNN-based breast cancer detection, evaluating deep learning architectures, feature extraction techniques, and optimization strategies. A comparative analysis of CNNs, recurrent neural networks (RNNs), and hybrid models highlights their strengths, limitations, and applicability in medical image classification. Using a dataset of 569 instances with 33 tumor morphology features, various deep learning architectures - including CNNs, long short-term memory networks (LSTMs), and multilayer perceptrons (MLPs) - were implemented, achieving classification accuracies between 89% and 98%. The study underscores the significance of data augmentation, transfer learning, and feature selection in improving model performance. Hybrid CNN-based models demonstrated superior predictive accuracy by capturing spatial and sequential dependencies within tumor feature sets. The findings support the potential of AI-driven breast cancer detection in clinical applications, reducing diagnostic errors and improving early detection rates. Future research should explore transformer-based models, federated learning, and explainable AI techniques to enhance interpretability, robustness, and generalization across diverse datasets.

Indexed as

breast cancer detectionconvolutional neural networks (cnns)data augmentationdeep learningexplainable ai (xai)federated learninghybrid modelsmachine learningmedical image classificationtransfer learning

Identifiers

PMID40322605
PMCPMC12049196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.